Reversal of Sensorimotor Gating Deficits in Brattleboro Rats by Acute Administration of Clozapine and a Neurotensin Agonist, but not Haloperidol: a Potential Predictive Model for Novel Antipsychotic Effects
- 4 February 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 29 (4), 731-738
- https://doi.org/10.1038/sj.npp.1300378
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?Seminars in Clinical Neuropsychiatry, 2003
- A Systemically Administered Neurotensin Agonist Blocks Disruption of Prepulse Inhibition Produced by a Serotonin-2A AgonistNeuropsychopharmacology, 2002
- Neurotensin: an endogenous antipsychotic?Current Opinion in Pharmacology, 2002
- Reduced amide bond neurotensin 8–13 mimetics with potent in vivo activityBioorganic & Medicinal Chemistry Letters, 1995
- Neurotensin Binding to DopamineJournal of Neurochemistry, 1990
- [3H]Neurotensin(8–13) Binds in Human Brain to the Same Sites as Does [3H]Neurotensin but with Higher AffinityJournal of Neurochemistry, 1988
- Altered emotionality of the vasopressin-deficient Brattleboro ratPeptides, 1985
- Behavioral differences between vasopressin-deficient (Brattleboro) and normal Long-Evans RatsPeptides, 1983
- Hyperreflexive behavior in Brattleboro ratsPeptides, 1983
- Correlation between multitest and single test catalepsy assessmentNeuropharmacology, 1978